ask="7.20"
ask_size="700"
average_daily_volume="75221"
bid="4.10"
bid_size="2000"
book_value="5.08"
change="+0.06"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="0.45"
change_from_52_week_high="-7.65"
change_From_52_week_low="1.44"
change_in_percent="+1.19%"
close="5.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.14"
high_52_weeks="12.75"
last_trade_date="2/16/2017"
last_trade_price="5.10"
last_trade_size="261"
last_trade_time="4:00pm"
low="4.95"
low_52_weeks="3.66"
market_capitalization="68.49M"
moving_average_200_day="5.62"
moving_average_50_day="4.65"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.98"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-9.33%"
percent_change_from_50_day_moving_average="+9.70%"
percent_change_from_52_week_high="-60.00%"
percent_change_from_52_week_low="+39.34%"
previous_close="5.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.99"
price_per_sales="13.63"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="115908"
weeks_range_52="3.66 - 12.75"
